METASTATIC BLADDER UROTHELIAL CARCINOMA
Clinical trials for METASTATIC BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced bladder cancer? drug targets specific gene mutations
Disease control Recruiting nowThis phase II trial is testing the drug pemetrexed in people with advanced bladder cancer or other solid tumors that have spread and carry certain gene mutations (MLL4, UTX, or MTAP). The goal is to see if pemetrexed can shrink tumors. About 64 participants will receive the drug …
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Blood 'Cleansing' may revive bladder cancer treatment
Disease control Recruiting nowThis study tests whether a procedure that filters a patient's blood (therapeutic plasma exchange) can help standard cancer drugs work better in people with advanced bladder or urinary tract cancer that has stopped responding to previous treatments. About 70 adults will be randoml…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Promising drug duo before bladder removal shows hope for advanced cancer patients
Disease control Recruiting nowThis study tests whether giving a targeted drug (enfortumab vedotin) plus an immunotherapy (pembrolizumab) before surgery to remove part or all of the bladder can improve outcomes for people with advanced bladder or urinary tract cancer. About 75 adults with cancer that has sprea…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New platform aims to predict which cancer treatments will work
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 participant…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC